Ametamey SM - Search Results

1

A Review of Molecular Imaging of Glutamate Receptors.

Kim JH, Marton J, Ametamey SM, Cumming P. Kim JH, et al. Among authors: ametamey sm. Molecules. 2020 Oct 16;25(20):4749. doi: 10.3390/molecules25204749. Molecules. 2020. PMID: 33081223 Free PMC article. Review.

2

Imaging the glutamate receptor subtypes-Much achieved, and still much to do.

Gruber S, Ametamey SM. Gruber S, et al. Among authors: ametamey sm. Drug Discov Today Technol. 2017 Nov;25:27-36. doi: 10.1016/j.ddtec.2017.10.006. Epub 2017 Nov 8. Drug Discov Today Technol. 2017. PMID: 29233264 Review.

3

Radioligands for the PET imaging of metabotropic glutamate receptor subtype 5 (mGluR5).

Mu L, Schubiger PA, Ametamey SM. Mu L, et al. Among authors: ametamey sm. Curr Top Med Chem. 2010;10(15):1558-68. doi: 10.2174/156802610793176783. Curr Top Med Chem. 2010. PMID: 20583985 Review.

4

Imaging glutamate redistribution after acute N-acetylcysteine administration: A simultaneous PET/MR study.

O'Gorman Tuura R, Warnock G, Ametamey S, Treyer V, Noeske R, Buck A, Sommerauer M. O'Gorman Tuura R, et al. Neuroimage. 2019 Jan 1;184:826-833. doi: 10.1016/j.neuroimage.2018.10.017. Epub 2018 Oct 5. Neuroimage. 2019. PMID: 30296554

5

Automated cGMP-compliant radiosynthesis of [¹⁸ F]-(E)-PSS232 for brain PET imaging of metabotropic glutamate receptor subtype 5.

Park JY, Son J, Yun M, Ametamey SM, Chun JH. Park JY, et al. Among authors: ametamey sm. J Labelled Comp Radiopharm. 2018 Jan;61(1):30-37. doi: 10.1002/jlcr.3566. Epub 2017 Dec 22. J Labelled Comp Radiopharm. 2018. PMID: 28948638

6

Preclinical Development of ¹⁸F-OF-NB1 for Imaging GluN2B-Containing N-Methyl-d-Aspartate Receptors and Its Utility as a Biomarker for Amyotrophic Lateral Sclerosis.

Ahmed H, Wallimann R, Haider A, Hosseini V, Gruber S, Robledo M, Nguyen TAN, Herde AM, Iten I, Keller C, Vogel V, Schibli R, Wünsch B, Mu L, Ametamey SM. Ahmed H, et al. Among authors: ametamey sm. J Nucl Med. 2021 Feb;62(2):259-265. doi: 10.2967/jnumed.120.246785. Epub 2020 Jul 31. J Nucl Med. 2021. PMID: 32737247 Free article.

7

Evaluation of the radiolabeled boronic acid-based FAP inhibitor MIP-1232 for atherosclerotic plaque imaging.

Meletta R, Müller Herde A, Chiotellis A, Isa M, Rancic Z, Borel N, Ametamey SM, Krämer SD, Schibli R. Meletta R, et al. Among authors: ametamey sm. Molecules. 2015 Jan 27;20(2):2081-99. doi: 10.3390/molecules20022081. Molecules. 2015. PMID: 25633335 Free PMC article.

8

Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.

Ametamey SM, Kessler LJ, Honer M, Wyss MT, Buck A, Hintermann S, Auberson YP, Gasparini F, Schubiger PA. Ametamey SM, et al. J Nucl Med. 2006 Apr;47(4):698-705. J Nucl Med. 2006. PMID: 16595505 Free article.

9

Structure-activity relationships of fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyloxime (ABP688) derivatives and the discovery of a high affinity analogue as a potential candidate for imaging metabotropic glutamate recepors subtype 5 (mGluR5) with positron emission tomography (PET).

Baumann CA, Mu L, Johannsen S, Honer M, Schubiger PA, Ametamey SM. Baumann CA, et al. Among authors: ametamey sm. J Med Chem. 2010 May 27;53(10):4009-17. doi: 10.1021/jm901850k. J Med Chem. 2010. PMID: 20411954

10

In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5).

Wanger-Baumann CA, Mu L, Honer M, Belli S, Alf MF, Schubiger PA, Krämer SD, Ametamey SM. Wanger-Baumann CA, et al. Among authors: ametamey sm. Neuroimage. 2011 Jun 1;56(3):984-91. doi: 10.1016/j.neuroimage.2011.03.024. Epub 2011 Mar 21. Neuroimage. 2011. PMID: 21406237

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page